All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mia.gets.better on TikTok · 72s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mia.gets.better's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I've lost over 100 pounds on a GLP one
  2. 0:02and this is a go-to dinner for us.
  3. 0:04Let me show you what I'm having.
  4. 0:05So just a little bit of rice and broccoli,
  5. 0:07nothing that fancy.
  6. 0:08This is the star of the show.
  7. 0:09This is called Unfried Chicken.
  8. 0:11It's a recipe that I got from Hello Fresh a while back.
  9. 0:14If you just take a chicken breast, you've seasoned it
  10. 0:16and then you put some sort of binding agents
  11. 0:18like mayo or sour cream.
  12. 0:20And then on top we mixed bread crumbs with cheese
  13. 0:24and buffalo sauce.
  14. 0:25You mix that and literally plop it on top of the chicken.
  15. 0:28Put in the oven at like what, 425 for 20 minutes.
  16. 0:31And that's it.
  17. 0:32And now I have like a high protein,
  18. 0:34super tasty, balanced dinner.
  19. 0:36This is what I need because if I'm not eating
  20. 0:39an easy dinner, especially when I'm gonna get full so fast,
  21. 0:43I'm not making a healthy dinner.
  22. 0:45Herping in a GLP one means like,
  23. 0:47I might not eat it all.
  24. 0:48So I'm not spending an hour cooking
  25. 0:50and this is like super low prep.
  26. 0:52Comment down below if you've ever tried this.
  27. 0:53You can do this with so many things.
  28. 0:54We've done like a ranch one,
  29. 0:57we've done Parmesan, like a chicken Parmesan.
  30. 1:00I'm sure there's so many ideas that we could do
  31. 1:03with this base.
  32. 1:04Comment down below.
  33. 1:05If you have any ideas, I would love to try them.
  34. 1:08Call me for more GLP one health and fitness related content.
  35. 1:10Have a great day. Bye.

GLP-1 weight loss and meal planning: what the science says

Mia • -100lbs 🏋🏻‍♀️🥊

TikTok creator

57.8K viewsWatch on TikTok

Quick answer

The creator is describing dietary adaptation during GLP-1 receptor agonist therapy, where significantly reduced appetite can make sustaining adequate protein intake difficult. Prioritizing high-protein, low-prep meals is a clinically reasonable strategy supported by obesity medicine guidelines, particularly given evidence from the STEP trial series showing lean mass losses alongside fat mass losses during GLP-1-assisted weight loss. No clinical claims were made in this video, and the content does not constitute medical advice.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 weight loss and meal planning: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 weight loss and meal planning: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 weight loss and meal planning: what the science says" from Mia • -100lbs 🏋🏻‍♀️🥊. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is describing dietary adaptation during GLP-1 receptor agonist therapy, where significantly reduced appetite can make sustaining adequate protein intake difficult.

The reason this review is not generic is the source wording and the canonical claim label "glp1 this is a dinner i ve eaten on repeat while losing over 100." In this clip, the useful excerpt is: "I've lost over 100 pounds on a GLP one and this is a go-to dinner for us." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Obesity medicine guidelines commonly recommend 1.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is describing dietary adaptation during GLP-1 receptor agonist therapy, where significantly reduced appetite can make sustaining adequate protein intake difficult.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is describing dietary adaptation during GLP-1 receptor agonist therapy, where significantly reduced appetite can make sustaining adequate protein intake difficult. Prioritizing high-protein, low-prep meals is a clinically reasonable strategy supported by obesity medicine guidelines, particularly given evidence from the STEP trial series showing lean mass losses alongside fat mass losses during GLP-1-assisted weight loss. No clinical claims were made in this video, and the content does not constitute medical advice.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide users lost an average of 14.9% body weight, but lean mass losses were observed, making protein-focused meals a priority, not just a preference.
  • Obesity medicine guidelines commonly recommend 1.2 to 1.6 grams of protein per kilogram of body weight for patients on GLP-1 therapy to help preserve muscle during rapid weight loss.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide users lost an average of 14.9% body weight, but lean mass losses were observed, making protein-focused meals a priority, not just a preference.
  • Obesity medicine guidelines commonly recommend 1.2 to 1.6 grams of protein per kilogram of body weight for patients on GLP-1 therapy to help preserve muscle during rapid weight loss.
  • A 2023 analysis (Idrees et al., Nutrients) found patients on appetite-suppressing medications were at elevated risk for inadequate protein and micronutrient intake when meal planning was not intentional.
  • Mayo-based binders add roughly 90-100 calories per tablespoon. For GLP-1 users eating smaller portions, topping calorie density can represent a larger share of total meal calories than expected.
  • The creator made no medical claims, prescribed no doses, and did not suggest the recipe has pharmacological interaction with GLP-1 medications. The content is appropriately framed as personal experience.
  • Tirzepatide (Jastreboff et al., 2022, NEJM) showed up to 22.5% mean body weight reduction in clinical trials, making 100+ pound losses over extended treatment periods clinically plausible for higher-weight individuals.
  • Building a rotation of quick, protein-dense meals before appetite suppression peaks is a strategy obesity medicine dietitians recommend proactively, making the practical framing in this video genuinely useful.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mia.gets.better actually say?

She described a baked breadcrumb-and-cheese-topped chicken breast as her repeat dinner while losing over 100 pounds on a GLP-1 medication. The core claim is practical: easy, high-protein meals are necessary when appetite suppression means you might not finish what you cook.

Her exact framing was that "being on a GLP one means like, I might not eat it all," so spending an hour cooking doesn't make sense. The meal she showed was chicken breast with a mayo or sour cream binder, breadcrumbs mixed with cheese and buffalo sauce, served alongside rice and broccoli, baked at 425°F for roughly 20 minutes. She didn't make specific calorie or macronutrient claims, and she didn't tell anyone to take a GLP-1 or suggest a dose. This was genuinely just a meal video with a GLP-1 lifestyle framing.

Does the science back this up?

The strategy of prioritizing high-protein, low-effort meals during GLP-1 therapy is actually well-supported. The concern isn't whether this specific recipe is magic, it's whether protein intake holds up when total food volume drops significantly.

Research published by Wharton et al. (2021, Obesity Reviews) and subsequent analyses of semaglutide trial data consistently show that a meaningful portion of weight lost on GLP-1 receptor agonists can include lean muscle mass, not just fat. The STEP 1 trial (Wilding et al., 2021, NEJM) reported average weight loss of about 14.9% body weight on semaglutide 2.4mg, but body composition data suggested lean mass losses warranting attention. Protein intake targets of 1.2 to 1.6 grams per kilogram of body weight are commonly recommended by obesity medicine practitioners specifically to offset this. A chicken breast-centered meal with a binding agent and cheese does contribute meaningfully to that protein load, so the instinct here is directionally correct.

What did they get wrong (or right)?

Honestly, she got most of this right. The practical logic is sound, and the meal itself is a reasonable choice. A few things are worth flagging.

First, the binding agent detail matters more than she let on. Mayo adds fat calories that some GLP-1 users tracking intake may not expect. A tablespoon of mayo is roughly 90-100 calories, and depending on how generously it's applied, this can meaningfully change the meal's profile. Sour cream is lower in calories but higher in saturated fat per tablespoon. Neither is a problem for most people, but calling the result "super low prep" while glossing over the caloric density of the toppings is a minor gap. Second, the rice portion she showed was small and she acknowledged it, which actually aligns with common GLP-1 dietary guidance to reduce refined carbohydrate load. Credit where it's due. Third, she didn't overclaim. She said this works for her. She didn't say it would work for everyone or that the recipe has any special GLP-1 synergy. That restraint is worth noting because a lot of GLP-1 content on TikTok does not show that restraint.

What should you actually know?

If you're on a GLP-1 medication and your appetite is significantly reduced, what you choose to eat in smaller volumes genuinely matters more, not less. This isn't about any single recipe being perfect.

The core issue is nutrient density per bite. When total intake drops, hitting protein, micronutrient, and fiber targets gets harder. A 2023 analysis by Idrees et al. (Nutrients) looking at dietary quality during pharmacological weight loss found that patients on appetite-suppressing medications were at elevated risk of inadequate protein and micronutrient intake if meal planning wasn't intentional. Chicken breast is one of the more protein-dense, calorie-efficient proteins available, so it's a reasonable anchor for a GLP-1-compatible meal. The broader takeaway from this video is valid even if it's presented casually: building a short list of quick, protein-forward dinners before hunger cues disappear is a practical strategy that obesity medicine dietitians routinely recommend. Just don't mistake "easy" for "automatically balanced." The broccoli and portion of rice she included matter too.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Mia • -100lbs 🏋🏻‍♀️🥊 · TikTok creator

57.8K views on this video

This is a dinner I’ve eaten on repeat while losing over 100 pounds on a GLP1. For me, dinners have to be easy and quick otherwise I’m eating snacks for dinner 😂 this unfried chicken from hello fresh is such a easy and tasty dinner! #glp1 #healthydinner #easydinner #dinnerideas #dinnerrecipe #healthyrecipes #healthyeating #100lbsdown

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) found?

The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide users lost an average of 14.9% body weight, but lean mass losses were observed, making protein-focused meals a priority, not just a preference.

What does the video say about obesity medicine guidelines commonly recommend 1.2 to 1.6 grams of?

Obesity medicine guidelines commonly recommend 1.2 to 1.6 grams of protein per kilogram of body weight for patients on GLP-1 therapy to help preserve muscle during rapid weight loss.

What does the video say about a 2023 analysis (idrees et al., nutrients) found patients on?

A 2023 analysis (Idrees et al., Nutrients) found patients on appetite-suppressing medications were at elevated risk for inadequate protein and micronutrient intake when meal planning was not intentional.

What does the video say about mayo-based binders add roughly 90-100 calories per tablespoon. for glp-1?

Mayo-based binders add roughly 90-100 calories per tablespoon. For GLP-1 users eating smaller portions, topping calorie density can represent a larger share of total meal calories than expected.

What does the video say about the creator made no medical claims, prescribed no doses,?

The creator made no medical claims, prescribed no doses, and did not suggest the recipe has pharmacological interaction with GLP-1 medications. The content is appropriately framed as personal experience.

What does the video say about tirzepatide (jastreboff et al., 2022, nejm) showed up to 22.5%?

Tirzepatide (Jastreboff et al., 2022, NEJM) showed up to 22.5% mean body weight reduction in clinical trials, making 100+ pound losses over extended treatment periods clinically plausible for higher-weight individuals.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Mia • -100lbs 🏋🏻‍♀️🥊, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.